Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2603)	4/13/2010 11:41:26 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

OPXA is up 5.86% on volume of 211Ks, still below its ADV. bigcharts.marketwatch.com It will be presenting tomorrow at the neurology meeting. It plans to present results of its PII of Tovaxin on MS patients. With some good news it could get to test the resistance from the Dec2 spike H at $3.19, but the Sep8 spike H at $6.93 looks too far at present.<g> bigcharts.marketwatch.com OPXA was able to trim its losses in the last 4Qs. The loss in 2009 was $0.35 vs. $1.12 in 2008 and for 2010 another slight trim in the loss is expected.<g> The insiders reportedly hold > 20% of the stock. Bernard